Sheba Medical Center

What Sheba Medical Center does

Sheba Medical Center is a government-affiliated public hospital located at Tel HaShomer in Ramat Gan, Israel, founded in 1948 and self-described as the largest medical center in the Middle East. The institution operates a comprehensive clinical care platform across multiple specialties and serves a general patient population, with revenue generated through standard hospital billing, insurance arrangements, and government funding. It also runs ARC, a wholly owned global health tech innovation arm that functions as both a startup accelerator and a clinical research services channel, providing trial infrastructure, GMP manufacturing, and patient access to pharmaceutical, biotech, and medical-device partners (e.g., Matricelf, Evinature, NurExone Biologic, Synchrony Medical, NeuroKaire).

The center's technology footprint is anchored by a set of AI and genomics capabilities developed with named partners. Core systems include Video-to-Vessels, a computer-vision tool co-developed with Tel Aviv University that estimates hemoglobin and anemia from eye imaging (82.8% accuracy across 224 participants); NGD200, a real-time genomic bacterial outbreak detection solution from NGD Infection Prevention (first Israeli deployment); ADAMS Copilot, a generative AI assistant from MDClone enabling natural-language queries of clinical and operational data; and a three-year Nvidia/Mount Sinai partnership using large language models to analyze 15,000 patients' genomic data for personalized medicine. ARC's commercial reach extends internationally via ARC Landing Boston, a U.S. accelerator launched with the state of Massachusetts, and via HealthTech Valley, a joint ecosystem with Bar-Ilan University. Customers and partners span biotech, pharma, medical devices, academic medical centers, and technology vendors across Israel, the U.S., and globally.

Name

Sheba Medical Center

Legal name

Sheba Medical Center

Website

https://eng.sheba.co.il

Company type

Private

Founded year

1948

Operating status

Operating

Headcount range

5,001–10,000 employees

Short description

Sheba Medical Center is Israel's largest hospital and the Middle East's largest medical center, delivering comprehensive patient care while running ARC, a health tech innovation arm that accelerates startups and runs AI-driven clinical research with global partners.

Ownership category

akta.pro rank

Product category

Hospital Healthcare Services

NAICS

General Medical and Surgical Hospitals (622110), General Medical and Surgical Hospitals (62211), General Medical and Surgical Hospitals (6221), Hospitals (622)

SIC

Services-General Medical & Surgical Hospitals, Nec (8062), Services-Hospitals (8060)

akta.pro primary industry

Academic Medical Centers (AMCs) & Teaching Hospitals (HLAFAAAA)

akta.pro secondary industries

Academic Medical Centers & Teaching Hospitals (University-Affiliated) (EDAHAGAA), Health Informatics & Digital Health Programs (EDAHAGAJ), International/Medical Tourism Hospital Systems (HLAFAAAN)

Keywords

• Hospital healthcare services
• Clinical research trials
• Health technology innovation
• Medical diagnostic services
• Patient care services

Headquarters

HQ city

Ramat Gan

HQ country

Israel

HQ region

Middle East

Offices2 records

Markets served

GTM type

B2B and B2C

Offering type

Services

Cost components

Personnel, Operations, Infrastructure, Technology or R&D, Marketing or Sales, Supply Chain, Others

Revenue model

1. Healthcare Services: Sheba Medical Center generates revenue through providing comprehensive medical services to patients, including hospital care, specialized treatments, surgeries, and diagnostic services.
2. Clinical Research Services: Conducting clinical trials for pharmaceutical and biotech companies, providing research infrastructure and patient access for drug development.

Go-to-market motion2 records

Distribution channels3 records

Marketing channels3 records

Core offering

Sheba Medical Center is the largest medical center in the Middle East, providing comprehensive hospital care including specialized treatments, surgeries, and diagnostic services to patients in Israel. Beyond direct care, it operates the ARC global health tech innovation arm, which accelerates health tech startups, runs the ARC Landing Boston accelerator, and conducts clinical research and trials in partnership with pharmaceutical, biotech, and technology companies such as Nvidia and Mount Sinai.

Product overview

Sheba Medical Center is a major medical center that operates both clinical care and health technology innovation through its ARC (Accelerator) arm. The center's technology offerings include AI diagnostic systems like Video-to-Vessels for non-invasive blood testing, genomic analysis tools like NGD200, and various clinical research collaborations. Through ARC Landing Boston, the center provides a startup accelerator for Israeli companies entering the U.S. market. HealthTech Valley represents an academic-industry partnership with Bar-Ilan University focused on medical technology research and development.

Differentiator

Problem solved

Functional benefit

Products and services

• Hospital Healthcare Services Comprehensive inpatient and outpatient hospital care at Sheba Medical Center's Tel HaShomer campus in Ramat Gan, Israel, including specialized treatments, surgeries, diagnostic services, and multi-specialty clinical programs for patients across Israel and the region.
• Clinical Research and Trial Services Clinical trial infrastructure and research services provided to pharmaceutical, biotechnology, and medical device companies, offering patient access, study site management, and translational research collaboration across multiple therapeutic areas.
• ARC Innovation Program Sheba's global health tech innovation arm, ARC, which accelerates healthcare technology startups, supports commercialization, and manages international partnerships including the ARC Landing Boston accelerator.
• HealthTech Valley Research Ecosystem Joint healthcare technology ecosystem between Sheba Medical Center and Bar-Ilan University on Bar-Ilan's campus near Ramat Gan, focusing on cancer research, advanced medical imaging, AI-driven diagnostics, and medical device development.
• Video-to-Vessels AI Diagnostic System AI-based system developed with Tel Aviv University that assesses hemoglobin levels and red blood cell counts by analyzing short video recordings of blood vessels in the eye's conjunctiva, achieving 82.8% accuracy in detecting anemia across 224 participants; targets clinics and regions with limited healthcare infrastructure.
• NGD200 Genomic Transmission Detection Real-time genomic detection system for bacterial outbreak prevention, deployed at Sheba Medical Center as the first installation in Israel; addresses drug-resistant infections through sequencing-based surveillance.

Quantifiable outcome

• 82.8% accuracy in detecting anemia from eye imaging
• +3 more outcomes

Named customers12 records

Segments5 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability9 records

Feature4 records

Partnerships

16 partnerships are on record, tiered core, flagship and minor.

• Tel Aviv UniversitycoreStrategic or Co-development Partner · 25 June 2026Joint development of Video-to-Vessels AI system for non-invasive blood testing. System analyzes video recordings of eye blood vessels to assess hemoglobin levels and red blood cell counts with 82.8% accuracy across 224 participants.
• Reichman UniversitycoreStrategic or Co-development Partner · 31 May 2026One-year MBA in Healthcare Innovation program bridging healthcare innovation concepts and practical implementation. Features Business Administration, Healthcare Management, and Innovation & Entrepreneurship pillars with hands-on practicums working on real ventures with healthcare organizations.
• NeuroKairecoreStrategic or Co-development Partner · 13 May 2026Clinical trials for BrightKaire AI and stem-cell based blood test that personalizes depression treatment, reducing treatment identification timeline from 12-18 months to two months. Also conducted at Geha Mental Health Center and Jefferson Hospital.
• Massachusetts (Governor Maura Healey)flagshipStrategic or Co-development Partner · 16 April 2026ARC Landing Boston - startup accelerator launched by Sheba's global health tech innovation arm ARC, debuting with six Israeli startups that have collectively raised $85 million. Provides gateway for Israeli companies to enter U.S. market while working with local healthcare facilities.
• Arletta Pharma SolutionscoreStrategic or Co-development Partner · 27 March 2026Phase II clinical trial of Lybrido for Female Sexual Interest/Arousal Disorder conducted at Sheba. Study on 16 premenopausal women showed more than 60% average improvement in clitoral blood flow with combination therapy.
• MatricelfcoreStrategic or Co-development Partner · 24 March 2026Strategic collaboration to support first-in-human clinical trial in spinal cord injury. Includes GMP manufacturing of neural tissue implants and clinical trial readiness efforts at Sheba, aiming to accelerate clinical timelines.
• EvinaturecoreStrategic or Co-development Partner · 18 March 2026DoD-funded clinical trial investigating CurQD nutraceutical formulation for ulcerative colitis in combination with vedolizumab. Conducted with Mount Sinai and University of Chicago Medicine. Initial $800,000 planning grant with potential up to $11 million total funding.
• MDClonecoreTechnology or Integration · 5 March 2026ADAMS Copilot - GenAI-powered healthcare data assistant deployed at Sheba Medical Center. Embedded within ADAMS platform to help clinical, operational, quality, and research teams explore and analyze real-world data through natural language interface.
• Synchrony MedicalcoreStrategic or Co-development Partner · 18 February 2026Joint development of LibAirty Airway Clearance System - FDA-cleared device for daily at-home respiratory therapy. Device clears twice as much sputum as conventional treatments, backed by Israel Innovation Authority.
• Bar-Ilan UniversitycoreStrategic or Co-development Partner · 31 December 2025Joint launch of HealthTech Valley - healthcare technology ecosystem on Bar-Ilan's campus near Ramat Gan. Described as Israel's most innovative healthcare technology ecosystem, focusing on cancer research, advanced imaging, AI diagnostics, and medical device development.
• NGD Infection PreventioncoreTechnology or Integration · 30 December 2025First deployment in Israel of NGD200 genomic transmission detection solution. System detects and prevents bacterial outbreaks in real-time, addressing drug-resistant infections. Part of broader expansion of sequencing technology in hospitals across the Middle East.
• MAPS IsraelcoreStrategic or Co-development Partner · 26 November 2025Clinical trial evaluating MDMA-assisted therapy for PTSD, sponsored by Sheba Medical Center. Involves 168 participants comparing group and individual therapy methods. GMP MDMA capsules supplied by Optimi Health.
• Mount Sinai HospitalflagshipStrategic or Co-development Partner · 21 November 2025Three-year AI partnership with Nvidia to analyze data from 15,000 patients and map the human genome using large language models. Aims to decode the 98% of human genome that remains poorly understood, with investment of tens of millions of dollars.
• NvidiaflagshipTechnology or Integration · 20 November 2025Collaboration to develop large language models trained on biological data for understanding and treating diseases based on individual genetics. Three-year project to decode human genome with investment of tens of millions of dollars.
• CustoMEDminorStrategic or Co-development Partner · 30 October 2025Technology originated from Sheba's 3D Printing & Innovation Lab. AI-driven platform for patient-specific orthopedic surgical solutions using 3D printing technology, already used in hundreds of successful surgeries worldwide.
• NurExone BiologiccoreStrategic or Co-development Partner · 9 October 2025Preclinical research collaboration with Prof. Ygal Rotenstreich's team at Sheba for ExoPTEN glaucoma treatment. Demonstrated dose-dependent therapeutic effect and measurable recovery of visual function in glaucoma eye model.

Scale indicators6 records

Recent moves8 records

Expansion highlights6 records

Direct peers

• Mayo Clinic: U.S.-based non-profit academic medical center globally recognized for integrated clinical care, research, and education. Comparable to Sheba in scale, reputation, and the combination of tertiary care with a strong research and innovation agenda.
• Cleveland Clinic: Large non-profit AMC with a global footprint and explicit focus on innovation and commercialization of clinical discoveries. Comparable to Sheba in combining high-acuity clinical care with a structured innovation function that spins out and partners with health tech ventures.
• Mount Sinai Health System: NYC-based AMC and an active Nvidia genomics partner with Sheba. Comparable as a research-intensive academic system pursuing AI-driven personalized medicine and large-scale genomic programs alongside traditional tertiary care.
• Charité – Universitätsmedizin Berlin: One of Europe's largest university hospitals and a leading research-driven AMC. Comparable to Sheba as a publicly-affiliated European/EMEA academic medical center combining patient care, translational research, and medtech/biotech collaboration.
• Karolinska University Hospital: Swedish academic medical center affiliated with Karolinska Institutet, known for research-intensive care and life-sciences commercialization. Comparable to Sheba as a publicly-funded, research-led European AMC with strong industry partnerships.
• Massachusetts General Hospital: Harvard-affiliated AMC and one of the leading U.S. research hospitals. Comparable to Sheba in clinical depth, research output, and attractiveness as a partner for biotech, pharma, and AI-in-health collaborations.
• Johns Hopkins Hospital: Top-tier U.S. research AMC with a global brand and a long track record of biotech and medtech commercialization. Comparable to Sheba in scale, reputation, and translational research intensity.
• Tel Aviv Sourasky Medical Center (Ichilov): Major publicly-affiliated Israeli AMC in Tel Aviv. Directly comparable as a domestic peer to Sheba in clinical services, research output, and competition for Israeli health-tech partnerships and talent.
• Hadassah Medical Center: Leading Israeli AMC with a strong research profile and international affiliations. Comparable to Sheba as another publicly-affiliated Israeli academic medical center competing for clinical, research, and innovation activity.

Broad incumbents

• King's College Hospital (NHS Foundation Trust): Large NHS-affiliated teaching hospital in London with significant research activity. Comparable as a publicly-funded European teaching hospital of similar scale, though more clinically-focused than innovation-led relative to Sheba.

Market position

Strengths4 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/sheba-tel-hashomer-city-of-health

Revenue estimate

Valuation estimate

Number of profiles

Profiles7 records

Subsidiaries2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Sheba Medical Center